Enveric Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Enveric Biosciences generated cash of -$14,094,411, which is more than the previous year. Cash used in financing activities reached the amount of -$1,343,141 last year. Net change in cash is therefore -$15,435,907.
Cash Flow
| 2014 | -43.16K | 0 | 48K |
|---|---|---|---|
| 2015 | -3.67M | -1.51M | 6.23M |
| 2016 | -2.70M | -6.59M | 8.79M |
| 2017 | -2.74M | -808.88K | 7.05M |
| 2018 | -2.56M | -3.63M | 2.69M |
| 2019 | -2.45M | -284.33K | 560 |
| 2020 | -3.88M | -44.14K | 5.53K |
| 2021 | -11.45M | 2.19M | 24.89M |
| 2022 | -17.14M | -584.16K | 18.18M |
| 2023 | -14.09M | 11.66K | -1.34M |
ENVB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 17.72M | 17.35M | 1.57M | 43.71K | 1.37M | 4.88M | 1.37M | 1.87M | 825.62K | 249 |
Operating activities | ||||||||||
Net income | -17.29M | -18.47M | -48.97M | -6.86M | -6.02M | -16.89M | -11.16M | -2.78M | -1.89M | -33.64K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 408.03K | 435.20K | 681.61K | 120.87K | 2.26M | 2.90M | 3.21M | 1.36M | 157.94K | 0 |
Stock-based compensation expense | 2.15M | 2.62M | 12.59M | 1.97M | 586.49K | 0 | 7.07M | 1.45M | 0 | 0 |
| Deferred income tax benefit | 2.15M | 2.62M | 12.59M | 1.97M | 586.49K | 0 | 7.07M | 1.45M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 1.48M | 967.03K | -778.54K | -3.18M | -2.30M | 0 |
Inventories | 0 | 0 | 0 | 0 | -222.67K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -103.84K | 263.68K | 383.19K | 267.00K | 222.67K | -2.10M | 620.78K | 3.60M | 0 | -13.73K |
Cash generated by operating activities | -14.09M | -17.14M | -11.45M | -3.88M | -2.45M | -2.56M | -2.74M | -2.70M | -3.67M | -43.16K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5.18K | -584.16K | -864.71K | -44.14K | -84.33K | 0 | -4.84K | -3.68M | -1.68M | 0 |
Acquisitions Net | 0 | 958.03K | 3.05M | 0 | -200K | -3.64M | -804.04K | -2.90M | 0 | 0 |
Cash generated by investing activities | 11.66K | -584.16K | 2.19M | -44.14K | -284.33K | -3.63M | -808.88K | -6.59M | -1.51M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 17.22M | 21.61M | 3.86M | 2.12M | 6.32M | 4.89M | 5M | 0 | 50K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -2.08B | 0 | 0 | 0 |
Repurchases of common stock | -1.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.67M | 0 | -1.97M | 0 | -3.79M | 6.23M | -2K |
Cash used in financing activities | -1.34M | 18.18M | 24.89M | 5.53K | 560 | 2.69M | 7.05M | 8.79M | 6.23M | 48K |
Net Change In Cash | -15.43M | 367.88K | 15.77M | 1.53M | -939.93K | -3.51M | 3.50M | -498.14K | 1.05M | 4.83K |
Cash at end of period | 2.28M | 17.72M | 17.35M | 1.57M | 431.4K | 1.37M | 4.88M | 1.37M | 1.87M | 5.08K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |